Home » Newsletters » BioWorld Asia

BioWorld Asia

May 20, 1998

View Archived Issues

Herpes Protein May Boost Gene Therapy Delivery Systems

Flamel Generates $10M To Support Drug Delivery

Theratechnologies Signs Major Alliance With Genetix

British Biotech's McCullagh To Resign Amid Controversy

Biota Shares Jump On FDA Filing

European Parliament Approves Stronger Patent Protections

Wellcome Counters Efforts In US To Control Genome Discoveries

Biotech International Gets Control Of Agen In A$18M Takeover

Vanguard On Track With Migraine Drug Despite Loss Of SmithKline

Phytopharm Begins Phase II For Osteoarthritis Treatment

Dendritic Cell Exosomes Function As Vaccine Vectors

Icon IPO Generates US$50M For Clinical Trial Services

Xenova Takes Anti-MDR Therapy Into Phase I Cancer Trials

Scotia Founder Departs In Dispute With New CEO

Cortecs Signs Glaxo Deal For Macritonin In Greece

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...
More than two to tango: multispecifics at ESMO TAT
BioWorld Science
Multispecifics took center stage at this year’s ESMO TAT, emerging as one of the hottest trends in oncology research. Unlike traditional small-molecule drugs or...